84 related articles for article (PubMed ID: 11549864)
1. Correlation between grade III placenta and plasma antithrombin III activity in full term pregnancy.
Asakura H; Ohshita T; Suzuki S; Araki T
Gynecol Obstet Invest; 2001; 52(1):47-50. PubMed ID: 11549864
[TBL] [Abstract][Full Text] [Related]
2. [Markers of hypercoagulability during pregnancy: thrombin-antithrombin-III complexes and D dimer].
Senent M; Bellart J; Zuazu-Jausoro I; Oliver A; Montserrat I; Ribera L; Tirado I; Cabero L; Fontcuberta J
Sangre (Barc); 1991 Feb; 36(1):21-4. PubMed ID: 1853270
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of grade III placenta in assessment of low level of plasma antithrombin III activity in pregnant women at term.
Asakura H; Nakai A; Araki T
J Nippon Med Sch; 2002 Oct; 69(5):415-21. PubMed ID: 12382000
[TBL] [Abstract][Full Text] [Related]
4. [A trial of setting of the reference intervals of thrombin antithrombin III complex and fibrin.fibrinogen degradation products in pregnant women].
Shizuka R; Amagai H; Kojima J; Imaizumi S; Fukumura Y; Kobayashi I; Takagi T; Ibuki Y
Rinsho Byori; 1994 Nov; 42(11):1194-8. PubMed ID: 7844893
[TBL] [Abstract][Full Text] [Related]
5. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of D-dimer: a crosslinked fibrin-degradation product in female breast cancer.
Mitter CG; Zielinski CC
J Cancer Res Clin Oncol; 1991; 117(3):259-62. PubMed ID: 2033094
[TBL] [Abstract][Full Text] [Related]
7. Coagulation/fibrinolysis disorder in patients with severe preeclampsia.
Kobayashi T; Tokunaga N; Sugimura M; Suzuki K; Kanayama N; Nishiguchi T; Terao T
Semin Thromb Hemost; 1999; 25(5):451-4. PubMed ID: 10625201
[TBL] [Abstract][Full Text] [Related]
8. Coagulation-fibrinolysis is more enhanced in twin than in singleton pregnancies.
Morikawa M; Yamada T; Turuga N; Cho K; Yamada H; Sakuragi N; Minakami H
J Perinat Med; 2006; 34(5):392-7. PubMed ID: 16965226
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery.
Reinthaller A; Mursch-Edlmayr G; Tatra G
Br J Obstet Gynaecol; 1990 Jun; 97(6):506-10. PubMed ID: 2198919
[TBL] [Abstract][Full Text] [Related]
10. Generation of thrombin in blood plasma of non-pregnant and pregnant women studied through concentration of thrombin-antithrombin III complexes.
Uszyński M
Eur J Obstet Gynecol Reprod Biol; 1997 Dec; 75(2):127-31. PubMed ID: 9447363
[TBL] [Abstract][Full Text] [Related]
11. [The clinical significance of thrombin-antithrombin III complex (TAT) and fibrinogen and fibrin degradation products (FDP) levels in ovarian cancer].
Sawaguchi K; Hojo T; Nozaki S; Yabushita H; Noguchi M; Nakanishi M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan; 44(1):73-8. PubMed ID: 1541865
[TBL] [Abstract][Full Text] [Related]
12. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
[TBL] [Abstract][Full Text] [Related]
13. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
14. [Soluble fibrin is not excreted in urine and its plasma level is elevated in nephrotic syndrome].
Morikawa T; Yamashiro Y; Okano K; Kasamatsu M; Sugai H; Kitamura H; Ohba I; Hotta O; Taguma Y; Sakurai J; Kitamoto Y
Rinsho Byori; 2009 Apr; 57(4):319-23. PubMed ID: 19489432
[TBL] [Abstract][Full Text] [Related]
15. Haemostasis in normal pregnancy.
Stirling Y; Woolf L; North WR; Seghatchian MJ; Meade TW
Thromb Haemost; 1984 Oct; 52(2):176-82. PubMed ID: 6084322
[TBL] [Abstract][Full Text] [Related]
16. D-dimer and thrombin-antithrombin III complex levels uncorrelated with phlebographic findings in 11 total knee replacement patients.
De Prost D; Ollivier V; Vie P; Benacerraf R; Duparc J; Khoury A
Ann Biol Clin (Paris); 1990; 48(4):235-8. PubMed ID: 2193559
[TBL] [Abstract][Full Text] [Related]
17. [Coagulation and fibrinolysis in pregnancy].
Yuasa S; Ishizawa M; Yuki Y; Minoura T; Fujita N; Takahashi H; Yoshimura M; Yamamoto T; Okada H
Rinsho Byori; 1992 Dec; 40(12):1287-91. PubMed ID: 1284915
[TBL] [Abstract][Full Text] [Related]
18. Is quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes useful to diagnose deep venous thrombosis in outpatients?
van Bergen PF; Knot EA; Jonker JJ; de Boer AC; de Maat MP
Thromb Haemost; 1989 Dec; 62(4):1043-5. PubMed ID: 2694421
[TBL] [Abstract][Full Text] [Related]
19. Hypercoagulability and DIC in high-risk infants.
Suzuki S; Morishita S
Semin Thromb Hemost; 1998; 24(5):463-6. PubMed ID: 9834014
[TBL] [Abstract][Full Text] [Related]
20. Thrombin-antithrombin III complexes and antithrombin III in amniotic fluid.
Uszyński M; Kielkowski A; Uszyński W; Zekanowska E
Gynecol Obstet Invest; 1997; 43(1):29-33. PubMed ID: 9015695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
